Publications

RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity

 65
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity

Tags:

Previous Article

‘Creeping fat’ can worsen Crohn’s disease

Next Article

Combination of RNA splicing factor and immunotherapy to treat neuroblastoma

Related Posts

DEP-1 is a brain insulin receptor phosphatase that prevents the simultaneous activation of counteracting metabolic pathways

DEP-1 is a brain insulin receptor phosphatase that prev...

 93

Matrin-3 forms spherical and wormlike assemblies that are modulated by RNA binding and ALS/FTD- associated mutations

Matrin-3 forms spherical and wormlike assemblies that ...

 71

Targeting conserved TIM3+VISTA+ tumor-associated macrophages overcomes resistance to cancer immunotherapy

Targeting conserved TIM3+VISTA+ tumor-associated macrop...

 95